BIRTH CONTROL

Press, Volume C, Issue 29504, 4 May 1961, Page 15

BIRTH CONTROL

Decision On New Drug

(N.Z P.A.-Reuter—Copyright) LONDON, May 2. The British Drug House Group might decide at the end of the year whether to market a new birth control pill in Britain, the annual report of the group’s chairman indicated today. The chairman. Mr Geoffrey Eley, says that the first news of the pill came about 14 months ago. | Clinical trials on humans began soon after, and were being undertaken in Britain in collaboration with the Council for the Investigation of Fertility Control. “The results so far obtained fully confirm the findings of our animal studies: but sufficient clinical evidence to support a decision to market the- pill is unlikely to accumulate before the end of the year.” Mr Eley said. “We had hoped for rather speedier results but there is nothing that we can do to expedite trials. “We are, of course, engaged in a field in which it is particularly important to be as sure as possible that the product will do what is required of it. and that it will be free from side effects ” Mr Eley said in the report that news of the discoveries had aroused interest throughout the world "and we have recently agreed to clinical trials in Canada, the United States and New Zealand. "Arrangements are also being made with the appropriate medical and family planning authorities ,in the Far East, where the need for population controls is especially urgent” he said Road maps tell a motorist everything he wants to know except how to fold them up again —Neal O’Hara.